OnKure will now hold its investor call to review preliminary data from the PIKture-01 study of OKI-219 on Tuesday, December 10, 2024 at 7:00 a.m. CT (8:00 a.m. ET). The Company had previously ...
Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters for vepdegestrant, including clinical data, will be presented (SABCS), being held December 10-13, 2024, in San Antonio, Texas.
The Small Business Forum is the City’s signature in-person event designed to support business owners and entrepreneurs. The 2024 event has concluded, however supports for the Toronto business ...